– The Project will benefit more than 11 million people as part of the fight against Covid-19
Havana, Jan 12 (Agencies) The Central American Bank for Economic Integration (CABEI) approved a first financing for 46.7 million euros for Cuba, an extra-regional member country, aimed at strengthening capacities in the development and production of medicines, medical equipment, diagnostics and anticovid-19 vaccines.
“We celebrate this first approval of the Republic of Cuba, which we hope will be the first of many. This particular operation will contribute to face the health crisis through the development of vaccines that reduce people’s risk of being infected by the covid-19 virus and will also contribute to the economic reactivation of the country «, declared the executive president of CABEI, Dr. Dante Mossi.
One of the specific objectives of the Project to Strengthen the Cuban Biopharmaceutical Industry to combat the virus in Cuba and in the region is to achieve higher levels of economic productivity through the development of innovative products of great importance in the context of the pandemic, and the modernization of technology, as well as diversification for the benefit of the National Health System and other countries in the region.
The loan also includes the strengthening of the productive infrastructure of the Cuban biopharmaceutical industry, allowing a greater production of injectable antibiotics, parenteral solutions (serums), generic and biosimilar drugs, diagnostics, medical equipment and specific vaccines against Covid19, as well as the acquisition of supplies and medical protection material to prevent contagion.
The Project will be in charge of the United Nations Development Program (UNDP), which will carry out the procurement in accordance with its policies and regulations.